SCHEMBL5652183

SCHEMBL5652183

Nc1cnc(NC(=O)c2ccc(F)cc2C(F)(F)F)nc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
AURKA O14965 6/20 0.44
CHEK2 O96017 1/20 0.44
CSF1R P07333 1/20 0.44
RET P07949 1/20 0.44
FLT4 P35916 1/20 0.44
ABL2 P42684 1/20 0.44
BLK P51451 1/20 0.44
LIMK1 P53667 1/20 0.44
AURKB Q96GD4 1/20 0.44
PTGS1 P23219 1/20 0.43
PTGES O14684 1/20 0.43
SORT1 Q99523 1/20 0.42
WDR5 P61964 8/20 0.42
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5652401 0.83 HDAC3 (0.43) HDAC3HDAC1HDAC2HDAC6AURKA
SCHEMBL679036 0.80 PTGS1 (0.52) HDAC1AURKACHEK2CSF1RRET
SCHEMBL1160893 0.76 AURKA (0.48) HDAC1AURKAPTGS1WDR5ALOX15
SCHEMBL5648961 0.74 CYP1A2 (0.54) HDAC1AURKAPTGS1
SCHEMBL1160927 0.74 HDAC1 (0.52) HDAC1AURKACHEK2CSF1RRET
SCHEMBL27489099 0.74 MEN1 (0.52) AURKACHEK2CSF1RRETFLT4
SCHEMBL13485802 0.74 LMNA (0.61) HDAC3HDAC1HDAC2HDAC6AURKA
SCHEMBL5235614 0.73 HCAR3 (0.52) HDAC3HDAC1HDAC2HDAC6PTGS1
SCHEMBL5237677 0.73 PTGES (0.46) HDAC3HDAC1HDAC2HDAC6AURKA
SCHEMBL1417617 0.72 KMT2A (0.49) AURKACHEK2CSF1RRETFLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7235559-B1 Therapeutic quinazoline derivatives ASTRAZENECA AB (SE) 2007-06-26 US disclosed
CN-1391563-A Therapeutic quinazoline derivatives ASTRAZENECA AB (SE) 2003-01-15 CN disclosed
EP-1218355-A1 THERAPEUTIC QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2002-07-03 EP disclosed
WO-2001021597-A1 THERAPEUTIC QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2001-03-29 WO disclosed